Cargando…
Tumor vessel co-option: The past & the future
Tumor vessel co-option (VCO) is a non-angiogenic vascularization mechanism that is a possible cause of resistance to anti-angiogenic therapy (AAT). Multiple tumors are hypothesized to primarily rely on growth factor signaling-induced sprouting angiogenesis, which is often inhibited during AAT. Durin...
Autores principales: | Cuypers, Anne, Truong, Anh-Co Khanh, Becker, Lisa M., Saavedra-García, Paula, Carmeliet, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472251/ https://www.ncbi.nlm.nih.gov/pubmed/36119528 http://dx.doi.org/10.3389/fonc.2022.965277 |
Ejemplares similares
-
Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative
por: Lugassy, Claire, et al.
Publicado: (2022) -
Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells
por: Cuypers, Anne, et al.
Publicado: (2022) -
Past, Present, and Future of Molecular and Cellular Oncology
por: Galluzzi, Lorenzo, et al.
Publicado: (2011) -
Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019) -
Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)